| scholarly article | Q13442814 |
| P50 | author | Brian R. Murphy | Q65658906 |
| Marisa St Claire | Q89881599 | ||
| P2093 | author name string | Alexander G Pletnev | |
| Brad W Finneyfrock | |||
| David M Asher | |||
| James M Speicher | |||
| Jerrold M Ward | |||
| Olga A Maximova | |||
| P2860 | cites work | Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys | Q27469631 |
| Tick-Borne Langat/Mosquito-Borne Dengue Flavivirus Chimera, a Candidate Live Attenuated Vaccine for Protection against Disease Caused by Members of the Tick-Borne Encephalitis Virus Complex: Evaluation in Rhesus Monkeys and in Mosquitoes | Q27469955 | ||
| West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy | Q27471660 | ||
| Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines | Q27472841 | ||
| A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys | Q27473080 | ||
| Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4 | Q27480832 | ||
| Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers | Q27485433 | ||
| Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice | Q27486063 | ||
| Epidemiology and ecology of TBE relevant to the production of effective vaccines | Q35082343 | ||
| Pathogenesis of flavivirus encephalitis | Q35613343 | ||
| Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates | Q35781967 | ||
| Yellow fever vaccine | Q36238729 | ||
| IABs scientific workshop on neurovirulence tests for live virus vaccines, January 31-February 1, 2005, Geneva | Q36300672 | ||
| Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses | Q37285066 | ||
| Morphological characterisitcs of the pathological process in the central nervous system of monkeys infected with variants of measles virus strain L-16 | Q39290961 | ||
| The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination | Q39785989 | ||
| Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. | Q40474846 | ||
| Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys | Q40500583 | ||
| Residual neurovirulence of the chimera of Langat and Denge-4 flaviviruses in intracerebral infection of monkeys | Q40513678 | ||
| Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys | Q40546858 | ||
| Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. | Q40593118 | ||
| Nucleotide sequence of the genome and complete amino acid sequence of the polyprotein of tick-borne encephalitis virus | Q40767643 | ||
| The neurovirulence of flaviviruses in crab-eating monkeys (Macaca fascicularis). | Q40803216 | ||
| Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice | Q40814578 | ||
| Histological studies of the monkey neurovirulence of group B arboviruses. II. Selection of indicator centers | Q40957886 | ||
| Histological studies of the monkey neurovirulence of group B arboviruses. I. A semiquantitative grading scale | Q40964293 | ||
| Visualization of Central European tick-borne encephalitis infection in fatal human cases | Q42480355 | ||
| Movement disorders in rhesus monkeys after infection with tick-borne encephalitis virus | Q42980248 | ||
| Sequence of the genes encoding the structural proteins of the low-virulence tick-borne flaviviruses Langat TP21 and Yelantsev | Q42985953 | ||
| Persistence of tick-borne encephalitis virus IV. Virus localization after intracerebral inoculation. | Q43001872 | ||
| Persistence of tick-borne encephalitis virus in monkeys. VI. Pathomorphology of chronic infection in central nervous system | Q43030256 | ||
| Inflammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue | Q43031318 | ||
| Epitope analysis of tick-borne encephalitis (TBE) complex viruses using monoclonal antibodies to envelope glycoprotein of TBE virus (persulcatus subtype). | Q43035279 | ||
| Comparative evaluation of neurovirulence of domestic and foreign live mumps vaccine | Q43489607 | ||
| Neurovirulence tests of type 3 oral poliovirus vaccine manufactured by Lederle Laboratories, 1964-1988. | Q44216841 | ||
| Histological studies of the monkey neurovirulence of group B arboviruses. IV. Evaluation of an attenuated strain (E5) of Langat virus | Q44992243 | ||
| Comparative analysis of virulence of the Siberian and Far-East subtypes of the tick-born encephalitis virus | Q45086158 | ||
| Virus and host factors influencing the titer of Lansing poliomyelitis virus in monkeys, cotton rats and mice | Q45580791 | ||
| A chick embryo attenuated strain (TP21 E5) of Langat virus. I. Virulence of the virus for mice and monkeys | Q45814146 | ||
| Comparative study on the neurovirulence of different vaccine strains of parotitis virus in monkeys | Q45840207 | ||
| Monkey neurovirulence test for live mumps vaccine | Q48922760 | ||
| Clinical picture and pathogenesis of progressive forms of experimental tick-borne encephalitis | Q54272969 | ||
| Histological studies of the monkey neurovirulence of group B arboviruses. 3. Relative virulence of selected viruses | Q68565731 | ||
| Monoclonal antibodies against tick-borne encephalitis virus glycoprotein: preliminary characterization | Q69276851 | ||
| Tick-borne encephalitis | Q73074722 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathogenesis | Q372016 |
| virulence | Q1460232 | ||
| neuropathogenesis | Q121363649 | ||
| P304 | page(s) | 5255-68 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Comparative Neuropathogenesis and Neurovirulence of Attenuated Flaviviruses in Nonhuman Primates | |
| P478 | volume | 82 |
| Q33909344 | Assurance of neuroattenuation of a live vaccine against West Nile virus: a comprehensive study of neuropathogenesis after infection with chimeric WN/DEN4Δ30 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine. |
| Q27489646 | Cellular Inflammatory Response to Flaviviruses in the Central Nervous System of a Primate Host |
| Q35046285 | Chimeric tick-borne encephalitis/dengue virus is attenuated in Ixodes scapularis ticks and Aedes aegypti mosquitoes |
| Q40119232 | Effect of a single point mutation on equine herpes virus 9 (EHV-9) neuropathogenicity after intranasal inoculation in a hamster model |
| Q27487013 | Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys |
| Q36096374 | Experimental West Nile Virus Infection in Rabbits: An Alternative Model for Studying Induction of Disease and Virus Control |
| Q36586306 | Experimental therapies for yellow fever |
| Q34384833 | High-throughput automated image analysis of neuroinflammation and neurodegeneration enables quantitative assessment of virus neurovirulence |
| Q34529812 | Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype |
| Q27488399 | Neuropathogenesis and Neurovirulence of Live Flaviviral Vaccines in Monkeys |
| Q37088625 | Single-dose vaccine against tick-borne encephalitis |
| Q63739989 | Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus |
| Q27980544 | The flavivirus dengue induces hypertrophy of white matter astrocytes |
| Q98158068 | The lymphocyte populations and their migration into the central nervous system in tick-borne encephalitis |
| Q34036778 | The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genome |
| Q37802595 | Tick-borne encephalitis virus and the immune response of the mammalian host |
| Q37006727 | Toll-like receptor 7 suppresses virus replication in neurons but does not affect viral pathogenesis in a mouse model of Langat virus infection |
| Q36513937 | Type I Interferon response in olfactory bulb, the site of tick-borne flavivirus accumulation, is primarily regulated by IPS-1. |
| Q27303511 | West Nile Virus Spreads Transsynaptically within the Pathways of Motor Control: Anatomical and Ultrastructural Mapping of Neuronal Virus Infection in the Primate Central Nervous System |
Search more.